TIME announces the recipients of the 2025 TIME100 AI Impact Awards, recognizing individuals who are moving their industries ...
Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback